Skip to main content
Top
Published in: Malaria Journal 1/2020

Open Access 01-12-2020 | Malaria | Opinion

Addressing budget reduction and reallocation on health-related resources during COVID-19 pandemic in malaria-endemic countries

Authors: Ajib Diptyanusa, Karen Nelwin Zablon

Published in: Malaria Journal | Issue 1/2020

Login to get access

Abstract

The global COVID-19 pandemic has been affecting the maintenance of various disease control programmes, including malaria. In some malaria-endemic countries, funding and personnel reallocations were executed from malaria control programmes to support COVID-19 response efforts, resulting mainly in interruptions of disease control activities and reduced capabilities of health system. While it is principal to drive national budget rearrangements during the pandemic, the long-standing malaria control programmes should not be left behind in order to sustain the achievements from the previous years. With different levels of intensity, many countries have been struggling to improve the health system resilience and to mitigate the unavoidable stagnation of malaria control programmes. Current opinion emphasized the impacts of budget reprioritization on malaria-related resources during COVID-19 pandemic in malaria endemic countries in Africa and Southeast Asia, and feasible attempts that can be taken to lessen these impacts.
Literature
1.
go back to reference Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207–11.CrossRef Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207–11.CrossRef
2.
go back to reference Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8:e1132–41.CrossRef Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8:e1132–41.CrossRef
3.
go back to reference Feachem RGA, Chen I, Akbari O, Bertozzi-Villa A, Bhatt S, Binka F, et al. Malaria eradication within a generation: ambitious, achievable, and necessary. Lancet. 2019;394:1056–112.CrossRef Feachem RGA, Chen I, Akbari O, Bertozzi-Villa A, Bhatt S, Binka F, et al. Malaria eradication within a generation: ambitious, achievable, and necessary. Lancet. 2019;394:1056–112.CrossRef
5.
go back to reference Mercado CEG, Ekapirat N, Dondorp AM, Maude RJ. An assessment of national surveillance systems for malaria elimination in the Asia Pacific. Malar J. 2017;16:127.CrossRef Mercado CEG, Ekapirat N, Dondorp AM, Maude RJ. An assessment of national surveillance systems for malaria elimination in the Asia Pacific. Malar J. 2017;16:127.CrossRef
6.
go back to reference WHO. A framework for malaria elimination. Geneva: World Health Organization; 2017. WHO. A framework for malaria elimination. Geneva: World Health Organization; 2017.
7.
go back to reference Guerra CA, Tresor Donfack O, Motobe Vaz L, Mba Nlang JA, Nze Nchama LO, Mba Eyono JN, et al. Malaria vector control in sub-Saharan Africa in the time of COVID-19: no room for complacency. BMJ Glob Health. 2020;5:e003880.CrossRef Guerra CA, Tresor Donfack O, Motobe Vaz L, Mba Nlang JA, Nze Nchama LO, Mba Eyono JN, et al. Malaria vector control in sub-Saharan Africa in the time of COVID-19: no room for complacency. BMJ Glob Health. 2020;5:e003880.CrossRef
8.
go back to reference WHO. The potential impact of health service disruptions on the burden of malaria: a modelling analysis for countries in sub-Saharan Africa. Geneva: World Health Organization; 2020a. WHO. The potential impact of health service disruptions on the burden of malaria: a modelling analysis for countries in sub-Saharan Africa. Geneva: World Health Organization; 2020a.
9.
go back to reference Rogerson SJ, Beeson JG, Laman M, Poespoprodjo JR, William T, Simpson JA, et al. Identifying and combating the impacts of COVID-19 on malaria. BMC Med. 2020;18:239.CrossRef Rogerson SJ, Beeson JG, Laman M, Poespoprodjo JR, William T, Simpson JA, et al. Identifying and combating the impacts of COVID-19 on malaria. BMC Med. 2020;18:239.CrossRef
11.
go back to reference Sherrard-Smith E, Hogan AB, Hamlet A, Watson OJ, Whittaker C, Winskill P, et al. The potential public health consequences of COVID-19 on malaria in Africa. Nat Med. 2020;26:1411–6.CrossRef Sherrard-Smith E, Hogan AB, Hamlet A, Watson OJ, Whittaker C, Winskill P, et al. The potential public health consequences of COVID-19 on malaria in Africa. Nat Med. 2020;26:1411–6.CrossRef
12.
go back to reference WHO. Coronavirus disease 2019 (COVID-19) situation report-15. Geneva: World Health Organization; 2020b. WHO. Coronavirus disease 2019 (COVID-19) situation report-15. Geneva: World Health Organization; 2020b.
13.
go back to reference Gendrot M, Javelle E, Clerc A, Savini H, Pradines B. Chloroquine as a prophylactic agent against COVID-19? Int J Antimicrob Agents. 2020;55:105980.CrossRef Gendrot M, Javelle E, Clerc A, Savini H, Pradines B. Chloroquine as a prophylactic agent against COVID-19? Int J Antimicrob Agents. 2020;55:105980.CrossRef
14.
go back to reference Uzun T, Toptas O. Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment? Chin Med. 2020;15:54.CrossRef Uzun T, Toptas O. Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment? Chin Med. 2020;15:54.CrossRef
15.
go back to reference Newton PN, Bond KC, Adeyeye M, Antignac M, Ashenef A, Awab GR, et al. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet Glob Health. 2020;8:e754–5.CrossRef Newton PN, Bond KC, Adeyeye M, Antignac M, Ashenef A, Awab GR, et al. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet Glob Health. 2020;8:e754–5.CrossRef
16.
go back to reference Pisani E, Nistor AL, Hasnida A, Parmaksiz K, Xu J, Kok MO. Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Tuekey and Romania. Wellcome Open Res. 2019;4:70.CrossRef Pisani E, Nistor AL, Hasnida A, Parmaksiz K, Xu J, Kok MO. Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Tuekey and Romania. Wellcome Open Res. 2019;4:70.CrossRef
17.
go back to reference Friedman EA, Gostin LO, Maleche A, Nilo A, Foguito F, Rugege U, et al. Global Health in the age of COVID-19: responsive health systems through a right to health fund. Health Hum Rights. 2020;22:199–207.PubMedPubMedCentral Friedman EA, Gostin LO, Maleche A, Nilo A, Foguito F, Rugege U, et al. Global Health in the age of COVID-19: responsive health systems through a right to health fund. Health Hum Rights. 2020;22:199–207.PubMedPubMedCentral
18.
go back to reference Kruk ME, Myers M, Varpilah ST, Dahn BT. What is a resilient health system? Lessons from Ebola. Ebola Lancet. 2015;385:1910–2.CrossRef Kruk ME, Myers M, Varpilah ST, Dahn BT. What is a resilient health system? Lessons from Ebola. Ebola Lancet. 2015;385:1910–2.CrossRef
Metadata
Title
Addressing budget reduction and reallocation on health-related resources during COVID-19 pandemic in malaria-endemic countries
Authors
Ajib Diptyanusa
Karen Nelwin Zablon
Publication date
01-12-2020
Publisher
BioMed Central
Keywords
Malaria
COVID-19
Published in
Malaria Journal / Issue 1/2020
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-020-03488-y

Other articles of this Issue 1/2020

Malaria Journal 1/2020 Go to the issue